277 related articles for article (PubMed ID: 18322215)
1. Functional CD8+ T cell responses in lethal Ebola virus infection.
Bradfute SB; Warfield KL; Bavari S
J Immunol; 2008 Mar; 180(6):4058-66. PubMed ID: 18322215
[TBL] [Abstract][Full Text] [Related]
2. Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection.
Warfield KL; Olinger G; Deal EM; Swenson DL; Bailey M; Negley DL; Hart MK; Bavari S
J Immunol; 2005 Jul; 175(2):1184-91. PubMed ID: 16002721
[TBL] [Abstract][Full Text] [Related]
3. Pathogenicity of Ebola and Marburg Viruses Is Associated With Differential Activation of the Myeloid Compartment in Humanized Triple Knockout-Bone Marrow, Liver, and Thymus Mice.
Lavender KJ; Williamson BN; Saturday G; Martellaro C; Griffin A; Hasenkrug KJ; Feldmann H; Prescott J
J Infect Dis; 2018 Nov; 218(suppl_5):S409-S417. PubMed ID: 30085162
[TBL] [Abstract][Full Text] [Related]
4. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.
Bengtsson KL; Song H; Stertman L; Liu Y; Flyer DC; Massare MJ; Xu RH; Zhou B; Lu H; Kwilas SA; Hahn TJ; Kpamegan E; Hooper J; Carrion R; Glenn G; Smith G
Vaccine; 2016 Apr; 34(16):1927-35. PubMed ID: 26921779
[TBL] [Abstract][Full Text] [Related]
5. A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
Callendret B; Vellinga J; Wunderlich K; Rodriguez A; Steigerwald R; Dirmeier U; Cheminay C; Volkmann A; Brasel T; Carrion R; Giavedoni LD; Patterson JL; Mire CE; Geisbert TW; Hooper JW; Weijtens M; Hartkoorn-Pasma J; Custers J; Grazia Pau M; Schuitemaker H; Zahn R
PLoS One; 2018; 13(2):e0192312. PubMed ID: 29462200
[TBL] [Abstract][Full Text] [Related]
6. NK Cells Accumulate in Infected Tissues and Contribute to Pathogenicity of Ebola Virus in Mice.
Fausther-Bovendo H; Qiu X; He S; Bello A; Audet J; Ippolito G; Wong G; Kobinger G
J Virol; 2019 May; 93(10):. PubMed ID: 30814283
[TBL] [Abstract][Full Text] [Related]
7. Persistent infection with ebola virus under conditions of partial immunity.
Gupta M; Mahanty S; Greer P; Towner JS; Shieh WJ; Zaki SR; Ahmed R; Rollin PE
J Virol; 2004 Jan; 78(2):958-67. PubMed ID: 14694127
[TBL] [Abstract][Full Text] [Related]
8. Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola Sequelae.
LaVergne SM; Sakabe S; Kanneh L; Momoh M; Al-Hassan F; Yilah M; Goba A; Sandi JD; Gbakie M; Cubitt B; Boisen M; Mayeux JM; Smira A; Shore K; Bica I; Pollard KM; Carlos de la Torre J; Branco LM; Garry RF; Grant DS; Schieffelin JS; Oldstone MBA; Sullivan BM
J Infect Dis; 2020 Oct; 222(9):1488-1497. PubMed ID: 32436943
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection.
Agrati C; Castilletti C; Casetti R; Sacchi A; Falasca L; Turchi F; Tumino N; Bordoni V; Cimini E; Viola D; Lalle E; Bordi L; Lanini S; Martini F; Nicastri E; Petrosillo N; Puro V; Piacentini M; Di Caro A; Kobinger GP; Zumla A; Ippolito G; Capobianchi MR
Cell Death Dis; 2016 Mar; 7(3):e2164. PubMed ID: 27031961
[TBL] [Abstract][Full Text] [Related]
10. Filovirus infection of STAT-1 knockout mice.
Raymond J; Bradfute S; Bray M
J Infect Dis; 2011 Nov; 204 Suppl 3():S986-90. PubMed ID: 21987780
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein.
Pinski A; Woolsey C; Jankeel A; Cross R; Basler CF; Geisbert T; Messaoudi I
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408171
[TBL] [Abstract][Full Text] [Related]
12. Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.
Rao M; Bray M; Alving CR; Jahrling P; Matyas GR
J Virol; 2002 Sep; 76(18):9176-85. PubMed ID: 12186901
[TBL] [Abstract][Full Text] [Related]
13. Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.
Warfield KL; Swenson DL; Negley DL; Schmaljohn AL; Aman MJ; Bavari S
Vaccine; 2004 Sep; 22(25-26):3495-502. PubMed ID: 15308377
[TBL] [Abstract][Full Text] [Related]
14. Discovery of common marburgvirus protective epitopes in a BALB/c mouse model.
Kalina WV; Warfield KL; Olinger GG; Bavari S
Virol J; 2009 Aug; 6():132. PubMed ID: 19712478
[TBL] [Abstract][Full Text] [Related]
15. Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.
Warfield KL; Olinger GG
J Biomed Biotechnol; 2011; 2011():984241. PubMed ID: 22253531
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms and consequences of ebolavirus-induced lymphocyte apoptosis.
Bradfute SB; Swanson PE; Smith MA; Watanabe E; McDunn JE; Hotchkiss RS; Bavari S
J Immunol; 2010 Jan; 184(1):327-35. PubMed ID: 20028660
[TBL] [Abstract][Full Text] [Related]
17. Human Ebola virus infection results in substantial immune activation.
McElroy AK; Akondy RS; Davis CW; Ellebedy AH; Mehta AK; Kraft CS; Lyon GM; Ribner BS; Varkey J; Sidney J; Sette A; Campbell S; Ströher U; Damon I; Nichol ST; Spiropoulou CF; Ahmed R
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4719-24. PubMed ID: 25775592
[TBL] [Abstract][Full Text] [Related]
18. A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge.
Grant-Klein RJ; Van Deusen NM; Badger CV; Hannaman D; Dupuy LC; Schmaljohn CS
Hum Vaccin Immunother; 2012 Nov; 8(11):1703-6. PubMed ID: 22922764
[TBL] [Abstract][Full Text] [Related]
19. Analysis of CD8
Sakabe S; Sullivan BM; Hartnett JN; Robles-Sikisaka R; Gangavarapu K; Cubitt B; Ware BC; Kotliar D; Branco LM; Goba A; Momoh M; Sandi JD; Kanneh L; Grant DS; Garry RF; Andersen KG; de la Torre JC; Sabeti PC; Schieffelin JS; Oldstone MBA
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7578-E7586. PubMed ID: 30038008
[TBL] [Abstract][Full Text] [Related]
20. Intranasal vaccination with ebola virus GP amino acids 258-601 protects mice against lethal challenge.
Su QD; He SH; Yi Y; Qiu F; Lu XX; Jia ZY; Meng QL; Fan XT; Tian RG; Audet J; Qiu XG; Bi SL
Vaccine; 2018 Oct; 36(41):6053-6060. PubMed ID: 30195490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
